These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2137847)

  • 1. Phenotypic and functional characterization of tumor infiltrating lymphocytes in mycosis fungoides: continuous growth of CD4+ CD45R+ T-cell clones with suppressor-inducer activity.
    Reinhold U; Pawelec G; Fratila A; Leippold S; Bauer R; Kreysel HW
    J Invest Dermatol; 1990 Mar; 94(3):304-9. PubMed ID: 2137847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocytes isolated from a Ki-1-positive large cell lymphoma of the skin. Phenotypic characterization and analysis of cytokine secretion.
    Reinhold U; Abken H; Kukel S; Goeden B; Uerlich M; Neumann U; Kreysel HW
    Cancer; 1991 Nov; 68(10):2155-60. PubMed ID: 1655203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
    Gervois N; Heuze F; Diez E; Jotereau F
    Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+CD45R-p80+ subpopulation.
    Damle NK; Childs AL; Doyle LV
    J Immunol; 1987 Sep; 139(5):1501-8. PubMed ID: 2887618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Con A-induced suppressor cell function depends on the activation of the CD4+CD45RA inducer T cell subpopulation.
    Sleasman JW; Henderson M; Barrett DJ
    Cell Immunol; 1991 Apr; 133(2):367-78. PubMed ID: 1826637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA.
    Wood GS; Dubiel C; Mueller C; Abel EA; Hoppe RT; Edinger A; Weissman I; Warnke RA
    Am J Pathol; 1991 Jun; 138(6):1545-52. PubMed ID: 1828937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a cord blood T cell subset of CD3+4-8-45R+ suppressing interleukin 2 production in the autologous mixed lymphocyte reaction and the mode of action of exogenous IL2 in the induction of IL2 production.
    Kawano Y; Noma T; Yata J
    Cell Immunol; 1990 Nov; 131(1):27-40. PubMed ID: 2146034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large cell mycosis fungoides at the tumor stage. Unusual T8, T4, T6 phenotypic expression.
    Horiuchi Y; Tone T; Umezawa A; Takezaki S
    Am J Dermatopathol; 1988 Feb; 10(1):54-8. PubMed ID: 2902810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
    Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL
    J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients.
    Pandolfi F; Boyle LA; Trentin L; Oliva A; Kurnick JT
    Clin Exp Immunol; 1994 Jan; 95(1):141-7. PubMed ID: 8287599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer.
    Ohta T; Kikuchi H; Ogata H; Iwata K; Yoshida K; Katayama K; Watanabe H
    Cancer; 1992 Aug; 70(4):741-8. PubMed ID: 1386555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
    Koide J; Engleman EG
    J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the CD8+CD45R+(2H4+) suppressor effector cell.
    Morimoto C; Takeuchi T; Schlossman SF
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S3-7. PubMed ID: 2532577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.
    Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL
    Int J Cancer; 1990 Nov; 46(5):878-83. PubMed ID: 2146230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell regulation of human B cell proliferation and differentiation. Regulatory influences of CD45R+ and CD45R- T4 cell subsets.
    Hirohata S; Lipsky PE
    J Immunol; 1989 Apr; 142(8):2597-607. PubMed ID: 2564858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.
    Raziuddin S; Elawad ME
    Clin Exp Immunol; 1990 Jan; 79(1):67-71. PubMed ID: 1967994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor.
    Tan P; Anasetti C; Martin PJ; Hansen JA
    J Immunol; 1990 Jul; 145(2):485-8. PubMed ID: 1973183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic shift in a case of mycosis fungoides with vitreous invasion.
    Lois N; Hiscott PS; Nash J; Wong D
    Arch Ophthalmol; 2000 Dec; 118(12):1692-4. PubMed ID: 11115267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors.
    Miescher S; Stoeck M; Qiao L; Barras C; Barrelet L; von Fliedner V
    Cancer Res; 1988 Dec; 48(24 Pt 1):6992-8. PubMed ID: 3263897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.